Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Celera Diagnostics and Merck & Co. enter Alzheimer's collaboration

Aug. 2, 2004

Acorda Therapeutics acquires Zanaflex rights from Elan

Aug. 2, 2004

New monoamine reuptake inhibitors discovered by Lilly researchers

Aug. 2, 2004

Ecgonine and ecgonidine analogues and their use reported by Entropin

Aug. 2, 2004

New data on mild cognitive impairment and its relationship with Alzheimer's disease

Aug. 2, 2004

Treatment with LXR agonist T-0901317 affects APP processing, ABCA1 upregulation and Abeta secretion

Aug. 2, 2004

Bifunctional drug inhibits beta-amyloid aggregation in vitro

Aug. 2, 2004

MRI improvements found with a single dose of natalizumab in relapsing MS patients

July 30, 2004

Completion of clinical portion of EXCEEDS phase IIIb study of Xyrem

July 30, 2004

Approvable letter for Ionsys

July 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...